FDA Warning Letter — Megafine Pharma (P) Limited
The FDA took a Warning Letter action against Megafine Pharma (P) Limited on February 24, 2017 (Vapi, India). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Megafine Pharma (P) Limited
- Date
- February 24, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Vapi (India)